MyFinsight
Home
Blog
About
Back
Income Statement
MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics (MLTX)
source: myfinsight.com
Of which net loss
attributable to controlling...
-$61,805K
(-11.93%↓ Y/Y)
Net loss
-$61,805K
(-10.27%↓ Y/Y)
Loss before income
tax
-$61,715K
(-10.29%↓ Y/Y)
Income tax expense
$90K
(-5.26%↓ Y/Y)
Other income, net
$2,577K
(-61.99%↓ Y/Y)
Operating loss
-$61,660K
(-1.58%↓ Y/Y)
Interest expense
$2,632K
(29.21%↑ Y/Y)
Total operating
expenses
$61,660K
(1.58%↑ Y/Y)
Research and development
$50,221K
(0.92%↑ Y/Y)
General and
administrative
$11,439K
(4.60%↑ Y/Y)
Back